- Report
- February 2024
- 160 Pages
Global
From €3503EUR$3,600USD£3,001GBP
- Report
- March 2024
- 200 Pages
Global
From €4038EUR$4,150USD£3,459GBP
- Report
- December 2023
- 180 Pages
Global
From €4665EUR$4,795USD£3,997GBP
- Report
- December 2023
- 80 Pages
United States
From €2525EUR$2,595USD£2,163GBP
- Report
- November 2023
- 320 Pages
Global
From €3099EUR$3,185USD£2,655GBP
€4427EUR$4,550USD£3,792GBP
- Report
- April 2024
- 183 Pages
Global
From €4768EUR$4,900USD£4,084GBP
- Report
- October 2023
- 84 Pages
Global
From €4768EUR$4,900USD£4,084GBP
- Report
- October 2023
- 185 Pages
Global
€4665EUR$4,795USD£3,997GBP
- Report
- April 2023
- 100 Pages
Global
From €5789EUR$5,950USD£4,959GBP
- Report
- January 2023
- 154 Pages
From €2043EUR$2,100USD£1,750GBP
€2919EUR$3,000USD£2,501GBP
- Report
- January 2023
- 229 Pages
Middle East, Africa
From €2043EUR$2,100USD£1,750GBP
€2919EUR$3,000USD£2,501GBP
- Report
- January 2023
- 152 Pages
North America
From €2043EUR$2,100USD£1,750GBP
€2919EUR$3,000USD£2,501GBP
- Report
- January 2023
- 151 Pages
Europe
From €2043EUR$2,100USD£1,750GBP
€2919EUR$3,000USD£2,501GBP
- Report
- January 2023
- 183 Pages
Asia Pacific
From €2043EUR$2,100USD£1,750GBP
€2919EUR$3,000USD£2,501GBP
- Report
- November 2022
- 291 Pages
Global
From €3099EUR$3,185USD£2,655GBP
€4427EUR$4,550USD£3,792GBP
- Report
- April 2023
- 111 Pages
Global
From €4622EUR$4,750USD£3,959GBP
- Report
- August 2022
- 120 Pages
Global
From €4622EUR$4,750USD£3,959GBP
- Report
- May 2020
- 111 Pages
Global
From €4622EUR$4,750USD£3,959GBP
- Report
- August 2023
- 75 Pages
India
From €3405EUR$3,500USD£2,917GBP
- Report
- December 2022
- 115 Pages
Global
From €4768EUR$4,900USD£4,084GBP
Artemisinin is a drug used to treat a variety of infectious diseases, including malaria, schistosomiasis, and filariasis. It is derived from the plant Artemisia annua, and is used in combination with other drugs to increase its effectiveness. Artemisinin is a potent antimalarial drug, and is the most effective treatment for malaria. It is also used to treat other parasitic infections, such as schistosomiasis and filariasis.
Artemisinin is available in a variety of forms, including tablets, capsules, and injections. It is also available in combination with other drugs, such as mefloquine, piperaquine, and doxycycline. The drug is generally well tolerated, with few side effects.
The Artemisinin market is highly competitive, with many companies offering the drug in various forms. Some of the companies in the market include Novartis, Sanofi, GlaxoSmithKline, Cipla, and Ranbaxy. Show Less Read more